ArticleHeliyon2022

Evaluation PD-L1, CD8 and CD20 as early predictor and tracking markers for breast cancer (BC) in Egypt.

Manar M Hamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.